This topic contains a solution. Click here to go to the answer

Author Question: Which of the following aspects of a study would be possible limitations on the usefulness of the ... (Read 108 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
Which of the following aspects of a study would be possible limitations on the usefulness of the results?
 
  A) the sample, the research design, the methods
  B) the conclusion, the discussion, the summary
  C) the population, the intervention, the control
  D) the setting, the method, the analysis

Question 2

The __________ can be used to adjust _________ when one of the assumptions for RM-ANOVA cannot be met. (Fill in the blanks.)
 
  a. Mauchly test, F statistic
  b. Mauchly test, df
  c. Huynh-Feldt epsilon, F statistic
  d. Huynh-Feldt epsilon, df



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

apple

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

A

Answer to Question 2

D




krzymel

  • Member
  • Posts: 548
Reply 2 on: Jul 8, 2018
YES! Correct, THANKS for helping me on my review


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Of the estimated 2 million heroin users in the United States, 600,000–800,000 are considered hardcore addicts. Heroin addiction is considered to be one of the hardest addictions to recover from.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

For a complete list of videos, visit our video library